Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, ...

With its ability to specifically inhibit the mutant IDH1 enzyme, TIBSOVO addresses an unmet need in personalized cancer treatment, offering new hope for patients with limited options. As clinical ...

Google has released its April 2025 Android Security Bulletin, which includes patches for 62 malicious bugs affecting Android ...

Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced our biotech innovation ...

NetApp® , the intelligent data infrastructure company, today announced that it has received the 2025 Google Cloud Infrastructure Modernization Partner of the Year for Storage award. NetApp is being ...

Geotab Inc. and its affiliates ("Geotab"), a global leader in connected transportation solutions is proud to announce that it has been awarded the Google Cloud Business Applications Partner Award in ...

How to Market Your Business on Social Media? 15 Strategies - Last I watched a local bookstore owner nearly break down in ...

While boosting morale is the USO’s stock-in-trade, the nonprofit wants service members and families to know they are so much ...

In addition to finalizing your baby registry list, planning a baby shower, and sending out baby shower invitations are a ...

Targeting Therapy Market, Drug Dosage, Patent, Sales & Clinical Trials Insight 2030 Report" report has been added to ResearchAndMarkets.com's offering.Global LAG-3 Targeting Therapy Market, Drug ...